312 related articles for article (PubMed ID: 28864646)
1. Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.
Sreih AG; Alibaz-Oner F; Kermani TA; Aydin SZ; Cronholm PF; Davis T; Easley E; Gul A; Mahr A; McAlear CA; Milman N; Robson JC; Tomasson G; Direskeneli H; Merkel PA
J Rheumatol; 2017 Dec; 44(12):1933-1937. PubMed ID: 28864646
[TBL] [Abstract][Full Text] [Related]
2. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.
Aydin SZ; Direskeneli H; Sreih A; Alibaz-Oner F; Gul A; Kamali S; Hatemi G; Kermani T; Mackie SL; Mahr A; Meara A; Milman N; Nugent H; Robson J; Tomasson G; Merkel PA
J Rheumatol; 2015 Dec; 42(12):2465-9. PubMed ID: 26077399
[TBL] [Abstract][Full Text] [Related]
3. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.
Aydin SZ; Robson JC; Sreih AG; Hill C; Alibaz-Oner F; Mackie S; Beard S; Gul A; Hatemi G; Kermani TA; Mahr A; Meara A; Milman N; Shea B; Tómasson G; Tugwell P; Direskeneli H; Merkel PA
J Rheumatol; 2019 Sep; 46(9):1198-1201. PubMed ID: 30877212
[TBL] [Abstract][Full Text] [Related]
4. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.
Direskeneli H; Aydin SZ; Kermani TA; Matteson EL; Boers M; Herlyn K; Luqmani RA; Neogi T; Seo P; Suppiah R; Tomasson G; Merkel PA
J Rheumatol; 2011 Jul; 38(7):1471-9. PubMed ID: 21724719
[TBL] [Abstract][Full Text] [Related]
5. Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review.
Boleto G; Berti A; Merkel PA; Aydin SZ; Direskeneli H; Dejaco C; Hassett LC; Carmona L; Ramiro S;
J Rheumatol; 2023 Jun; 50(6):789-798. PubMed ID: 36319004
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.
Aydin SZ; Direskeneli H; Merkel PA;
J Rheumatol; 2017 Dec; 44(12):1928-1932. PubMed ID: 28864648
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis.
Koster MJ; Matteson EL; Warrington KJ
Curr Opin Rheumatol; 2016 May; 28(3):211-7. PubMed ID: 26885650
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound imaging in the diagnosis of large vessel vasculitis.
Czihal M; Lottspeich C; Hoffmann U
Vasa; 2017 Jul; 46(4):241-253. PubMed ID: 28332442
[TBL] [Abstract][Full Text] [Related]
9. Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.
Robson JC; Almeida C; Dawson J; Bromhead A; Dures E; Guly C; Hoon E; Mackie S; Ndosi M; Pauling J; Hill C
Rheumatology (Oxford); 2021 Oct; 60(10):4671-4680. PubMed ID: 33528002
[TBL] [Abstract][Full Text] [Related]
10. Current status of outcome measure development in vasculitis.
Merkel PA; Aydin SZ; Boers M; Cornell C; Direskeneli H; Gebhart D; Hatemi G; Luqmani R; Matteson EL; Milman N; Robson J; Seo P; Tomasson G
J Rheumatol; 2014 Mar; 41(3):593-8. PubMed ID: 24429177
[TBL] [Abstract][Full Text] [Related]
11. Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.
Hatemi G; Meara A; Ozguler Y; Direskeneli H; Mahr A; Easley E; Gurcan M; Davis T; Gul A; Yazici Y; Zottenberg K; Esatoglu SN; Erer B; Kamali S; Yazici H; Cronholm PF; Merkel PA
J Rheumatol; 2017 Nov; 44(11):1750-1753. PubMed ID: 28365574
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab: a new therapy for large vessel vasculitis.
Al-Homood IA
Clin Exp Med; 2014 Nov; 14(4):355-60. PubMed ID: 23949338
[TBL] [Abstract][Full Text] [Related]
13. [Large vessel vasculitis].
Weigand S; Fleck M
Z Rheumatol; 2014 Jun; 73(5):447-55; quiz 456-7. PubMed ID: 24924731
[TBL] [Abstract][Full Text] [Related]
14. A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis.
Misra DP; Sharma A; Kadhiravan T; Negi VS
Autoimmun Rev; 2017 Feb; 16(2):179-191. PubMed ID: 27988436
[TBL] [Abstract][Full Text] [Related]
15. Biotherapies in large vessel vasculitis.
Pazzola G; Muratore F; Pipitone N; Salvarani C
Rev Med Interne; 2016 Apr; 37(4):274-8. PubMed ID: 26383765
[TBL] [Abstract][Full Text] [Related]
16. PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.
Pelletier-Galarneau M; Ruddy TD
Curr Cardiol Rep; 2019 Mar; 21(5):34. PubMed ID: 30887249
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of large vessel involvement in large vessel vasculitis.
Vautier M; Dupont A; de Boysson H; Comarmond C; Mirault T; Mekinian A; Lambert M; Ferfar Y; Aouba A; Cacoub P; Resche-Rigon M; Saadoun D
J Autoimmun; 2020 Mar; 108():102419. PubMed ID: 32035747
[TBL] [Abstract][Full Text] [Related]
18. Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years.
Delaval L; Daumas A; Samson M; Ebbo M; De Boysson H; Liozon E; Dupuy H; Puyade M; Blockmans D; Benhamou Y; Sacré K; Berezne A; Devilliers H; Pugnet G; Maurier F; Zénone T; de Moreuil C; Lifermann F; Arnaud L; Espitia O; Deroux A; Grobost V; Lazaro E; Agard C; Balageas A; Bouiller K; Durel CA; Humbert S; Rieu V; Roriz M; Souchaud-Debouverie O; Vinzio S; Nguyen Y; Régent A; Guillevin L; Terrier B
Autoimmun Rev; 2019 Jul; 18(7):714-720. PubMed ID: 31059846
[TBL] [Abstract][Full Text] [Related]
19. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure.
El Miedany Y; El Gaafary M; Toth M; Palmer D; Ali A; Bahlas S; Mahran S; Hassan W; Abu-Zaid MH; Saber S; Elwakil W
Semin Arthritis Rheum; 2023 Dec; 63():152285. PubMed ID: 37944298
[TBL] [Abstract][Full Text] [Related]
20. A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitis.
Bechman K; Gopalan D; Nihoyannopoulos P; Mason JC
Semin Arthritis Rheum; 2017 Oct; 47(2):241-246. PubMed ID: 28502640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
